Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 2 , Pages 133-137 , June 2009

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas

  • Peng-Hui Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Peng-Hui Wang, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital and National Yang-Ming University, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan
    • ,
  • Wen-Ling Lee

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Division of Endocrinology and Metabolism, Department of Medicine, Cheng Hsin Rehabilitation Center–Taipei, Taipei, Taiwan
    • ,
  • Ming-Huei Cheng

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • ,
  • Ming-Shyen Yen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Kuan-Chong Chao

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Hsiang-Tai Chao

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

,Accepted 27 March 2008.

References 

  1. Practice Committee of the American Society for Reproductive Medicine  . Myomas and reproductive function . Fertil Steril . 2006;86(Suppl 5):S194–S199
  2. Parker WH . Etiology, symptomatology, and diagnosis of uterine myomas . Fertil Steril . 2007;87:725–736
  3. Cheng MH , Chao HT , Wang PH . Unusual clinical presentation of uterine myomas . Taiwan J Obstet Gynecol . 2007;46:323–324
  4. Cheng MH , Chao HT , Wang PH . Medical treatment for uterine myomas . Taiwan J Obstet Gynecol . 2008;47:18–23
  5. Wen KC , Sung PL , Chao KC , Lee WL , Liu WM , Wang PH . A prospective short-term evaluation of uterine leiomyomas treated by myomectomy through conventional laparotomy or ultraminilaparotomy . Fertil Steril . 2008;90:2361–2366
  6. Wang PH , Liu WM , Fuh JL , Chao HT , Yuan CC , Chao KC . Comparison of ultraminilaparotomy for myomectomy through midline vertical incision or modified Pfannenstiel incision—a prospective short-term follow-up . Fertil Steril . 2009;91:1945–1950
  7. Parker WH . Uterine myomas: management . Fertil Steril . 2007;88:255–271
  8. Taylor E , Gomel V . The uterus and fertility . Fertil Steril . 2008;89:1–16
  9. Di Spiezio Sardo A , Mazzon I , Gargano V , et al.   Hysteroscopic treatment of atypical polypoid adenomyoma diagnosed incidentally in a young infertile woman . Fertil Steril . 2008;89:9–12 456,
  10. Liu WM , Tzeng CR , Chen YJ , Wang PH . Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids . Fertil Steril . 2004;82:205–210
  11. Liu WM , Ng HT , Wu YC , Yen YK , Yuan CC . Laparoscopic bipolar coagulation of uterine vessels: a new method for treating symptomatic fibroids . Fertil Steril . 2001;75:417–422
  12. Liu WM , Wang PH , Chou CS , Tang WL , Wang IT , Tzeng CR . Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas . Fertil Steril . 2007;87:356–361
  13. Wang PH , Chao HT , Lee WL . Rationale of myomectomy for perimenopausal women . Maturitas . 2007;58:406–407
  14. Gavai M , Berkes E , Takacs ZF , Papp Z . Can myomectomy be suggested for perimenopausal women before administering hormone replacement therapy? . Maturitas . 2007;58:107–110
  15. Cheng MH , Wang PH . Uterine myoma: a condition amenable to medical therapy? . Expert Opin Emerg Drugs . 2008;13:119–133
  16. Lee WL , Yuan CC , Wang PH . Positron emission tomography and uterine leiomyomas . Gynecol Oncol . 2007;107:593–594
  17. Lee WL , Liu RS , Yuan CC , Chao HT , Wang PH . Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography . Fertil Steril . 2001;75:638–639
  18. Chia CC , Huang SC , Chen SS , et al.   Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog . Taiwan J Obstet Gynecol . 2006;45:124–128
  19. Imai A , Sugiyama M , Furui T , Tamaya T . Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause . J Obstet Gynaecol . 2003;23:518–520
  20. Fedele L , Bianchi S , Frontino G . Hormonal treatments for adenomyosis . Best Pract Res Clin Obstet Gynaecol . 2008;22:333–339
  21. Clayton RN . Gonadotrophin-releasing hormone: its actions and receptors . J Endocrinol . 1989;120:11–19
  22. Friedman AJ , Lobel SM , Rein MS , Barbieri RL . Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis . Am J Obstet Gynecol . 1990;163:1114–1119
  23. Lethaby A , Vollenhoven B , Sowter M . Efficacy of preoperative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review . Br J Obstet Gynaecol . 2002;109:1097–1108
  24. Cirkel U , Ochs H , Schneider HP , et al.   Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study . Clin Ther . 1992;14:37–50
  25. Matta WH , Shaw RW , Nye M . Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin . Br J Obstet Gynaecol . 1989;96:200–206
  26. Rein MS , Friedman AJ , Stuart JM , MacLaughlin DT . Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate . Fertil Steril . 1990;53:1018–1023
  27. Donnez J , Hervais Vivancos B , Kudela M , Audebert A , Jadoul P . A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy . Fertil Steril . 2003;79:1380–1389
  28. Broekmans FJ, Hompes PG, Heitbrink MA, Netelenbos CC, Roos JC, Falke TM, et al. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy . Am J Obstet Gynecol . 1996;175:1208–1216
  29. Friedman AJ , Daly M , Juneau-Norcross M , Gleason R , Rein MS , Leboff M . Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin “add back” for 2 years . Hum Reprod . 1994;9:1618–1625
  30. Vercellini P , Sacerdote P , Trespidi L , Manfredi B , Panerai AE , Crosignani PG . Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study . Fertil Steril . 1994;62:938–942
  31. Palomba S , Orio F , Russo T , et al.   Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas . Hum Reprod . 2004;19:1308–1314
  32. Palomba S , Orio F , Falbo A , Oppedisano R , Tolino A , Zullo F . Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas . Fertil Steril . 2008;90:165–173
  33. Lee WL , Cheng MH , Chao HT , Wang PH . The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene . Taiwan J Obstet Gynecol . 2008;47:24–31
  34. Wang PH , Chao HT . A reconsideration of tamoxifen use for breast cancer . Taiwan J Obstet Gynecol . 2007;46:93–95
  35. Wang PH , Horng HC , Cheng MH , Chao HT , Chao KC . Standard and low-dose hormone therapy for postmenopausal women—focus on the breast . Taiwan J Obstet Gynecol . 2007;46:127–134
  36. Wang PH , Cheng MH , Chao HT , Chao KC . Effects of tibolone on the breast of postmenopausal women . Taiwan J Obstet Gynecol . 2007;46:121–126
  37. Wang PH , Yen MS , Chao KC , Liu CM , Lee WL . The shortterm effect of increased body weight in menopausal Chinese women taking tibolone . Maturitas . 2008;59:281–282
  38. Chao KC, Wang PH, Yen MS, Huang CY, Juang CM, Twu NF, et al. New selective tissue estrogenic activity regulator in menopausal therapy in Taiwan . Taiwan J Obstet Gynecol . 2005;44:327–331
  39. Chen FP . Hormone therapy and cardiovascular disease . Taiwan J Obstet Gynecol . 2006;45:287–293

PII: S1028-4559(09)60273-4

doi: 10.1016/S1028-4559(09)60273-4

Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 2 , Pages 133-137 , June 2009

Article Tools